Get started
Amphastar Pharmaceuticals, Inc. 2.0% 15-MAR-2029Amphastar Pharmaceuticals, Inc. 2.0% 15-MAR-2029Amphastar Pharmaceuticals, Inc. 2.0% 15-MAR-2029

Amphastar Pharmaceuticals, Inc. 2.0% 15-MAR-2029

No trades
No trades
OverviewProfile
Full chart
Full chart

Key terms


Outstanding amount
‪345.00 M‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
2.00%
Coupon frequency
Semi-annual
Maturity date
Mar 15, 2029
Term to maturity
2 years

Details


Issuer
Amphastar Pharmaceuticals, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
amphastar.com
Issue date
Sep 16, 2024
ISIN
US03209RAB96
CUSIP
03209RAB9
FIGI
BBG01J9HH831
Identifiers
ISIN US03209RAB96
CFI code
DCFNFR
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Profile


Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.